{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:57:32Z","timestamp":1790204252218,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008291","name":"University of Nebraska Medical Center College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005332","name":"Alpha Omega Alpha Honor Medical Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.heliyon.2021.e06756","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T09:39:17Z","timestamp":1618825157000},"page":"e06756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["APE1 and SSRP1 is overexpressed in muscle invasive bladder cancer and associated with poor survival"],"prefix":"10.1016","volume":"7","author":[{"given":"Heyu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1097-3020","authenticated-orcid":false,"given":"Jiping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Lele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A.","family":"LaGrange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor K.","family":"Bhakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2021.e06756_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.heliyon.2021.e06756_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2021.e06756_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/ars.2005.7.367","article-title":"The intracellular localization of APE1\/Ref-1: more than a passive phenomenon?","volume":"7","author":"Tell","year":"2005","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.heliyon.2021.e06756_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ctrv.2009.12.006","article-title":"Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer","volume":"36","author":"Abbotts","year":"2010","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.heliyon.2021.e06756_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mam.2007.04.005","article-title":"The DNA base excision repair protein Ape 1\/Ref-1 as a therapeutic and chemopreventive target","volume":"28","author":"Fishel","year":"2007","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.heliyon.2021.e06756_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cbf.3100","article-title":"A\u00a0review on protein-protein interaction network of APE1\/Ref-1 and its associated biological functions","volume":"33","author":"Thakur","year":"2015","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.heliyon.2021.e06756_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ctrv.2009.12.006","article-title":"Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer","volume":"36","author":"Abbotts","year":"2010","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.heliyon.2021.e06756_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00401-16","article-title":"Human apurinic\/apyrimidinic endonuclease (APE1) is acetylated at DNA damage sites in chromatin, and acetylation modulates its DNA repair activity","volume":"37","author":"Roychoudhury","year":"2017","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2021.e06756_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9010003","article-title":"Stabilization of nucleosomes by histone tails and by FACT revealed by spFRET microscopy","volume":"9","author":"Valieva","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2021.e06756_bib10","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1073\/pnas.1222198110","article-title":"Histone chaperone FACT action during transcription through chromatin by RNA polymerase II","volume":"110","author":"Hsieh","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2021.e06756_bib11","series-title":"Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer","author":"Song","year":"2019"},{"key":"10.1016\/j.heliyon.2021.e06756_bib12","doi-asserted-by":"crossref","first-page":"22590","DOI":"10.18632\/oncotarget.8026","article-title":"Regulation of limited N-terminal proteolysis of APE1 in tumor via acetylation and its role in cell proliferation","volume":"7","author":"Bhakat","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2021.e06756_bib13","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol."},{"key":"10.1016\/j.heliyon.2021.e06756_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.celrep.2013.06.013","article-title":"Facilitates chromatin transcription complex is an \"accelerator\" of tumor transformation and potential marker and target of aggressive cancers","volume":"4","author":"Garcia","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.heliyon.2021.e06756_bib15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/1535-7163.679.3.6","article-title":"Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition","volume":"3","author":"Wang","year":"2004","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.heliyon.2021.e06756_bib16","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1093\/nar\/22.23.4884","article-title":"A\u00a0role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress","volume":"22","author":"Walker","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2021.e06756_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1749-6632.1994.tb52834.x","article-title":"Biological responses of human apurinic endonuclease to radiation-induced DNA damage","volume":"726","author":"Chen","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2021.e06756_bib18","first-page":"3008","article-title":"The apurinic\/apyrimidinic endonuclease activity of Ape 1\/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress","volume":"8","author":"Silber","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2021.e06756_bib19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4143\/crt.2014.074","article-title":"APE1\/Ref-1 as a serological biomarker for the detection of bladder cancer","volume":"47","author":"Shin","year":"2015","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.heliyon.2021.e06756_bib20","doi-asserted-by":"crossref","first-page":"7276502","DOI":"10.1155\/2016\/7276502","article-title":"Urinary APE1\/ref-1: a potential bladder cancer biomarker","volume":"2016","author":"Choi","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.heliyon.2021.e06756_bib21","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1158\/1078-0432.CCR-05-0045","article-title":"APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer","volume":"11","author":"Sak","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2021.e06756_bib22","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3892\/or.2015.4151","article-title":"Impact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder","volume":"34","author":"Chantre-Justino","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2021.e06756_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2559.1998.00541.x","article-title":"Expression and subcellular localization of human AP endonuclease 1 (HAP1\/Ref-1) protein: a basis for its role in human disease","volume":"33","author":"Kakolyris","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.heliyon.2021.e06756_bib24","first-page":"1794","article-title":"Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence","volume":"57","author":"Kakolyris","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2021.e06756_bib25","article-title":"Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic","volume":"1","author":"Shah","year":"2017","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.heliyon.2021.e06756_bib26","doi-asserted-by":"crossref","first-page":"eaav2131","DOI":"10.1126\/sciadv.aav2131","article-title":"Mechanism of FACT removal from transcribed genes by anticancer drugs curaxins","volume":"4","author":"Chang","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.heliyon.2021.e06756_bib27","doi-asserted-by":"crossref","first-page":"18369","DOI":"10.1074\/jbc.R110.180778","article-title":"The histone chaperone FACT: structural insights and mechanisms for nucleosome reorganization","volume":"286","author":"Winkler","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2021.e06756_bib28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1089\/ars.2010.3410","article-title":"Functional analysis of novel analogues of E3330 that block the redox signaling activity of the multifunctional AP endonuclease\/redox signaling enzyme APE1\/Ref-1","volume":"14","author":"Kelley","year":"2011","journal-title":"Antioxidants Redox Signal."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021008598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021008598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:37:04Z","timestamp":1752583024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021008598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2405844021008598"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06756","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APE1 and SSRP1 is overexpressed in muscle invasive bladder cancer and associated with poor survival","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e06756"}}